Markets:

Overview

News

Currencies

International

Treasuries

Applied DNA Sciences, Inc. - Common Stock (NQ:APDN)

5.620 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Applied DNA Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

LTRPA, LTRPB Stock Alert: What Is Going on With Liberty TripAdvisor? ↗

August 02, 2022

Liberty TripAdvisor (LTRPA,LTRPB) stock is on a wild ride recently after the company received a delisting warning from the Nasdaq Exchange.

Via InvestorPlace

Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session ↗

August 02, 2022

Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.

Via Benzinga

Applied DNA Raises $4.2M Via Registered Direct Offering ↗

February 25, 2022

Applied DNA Sciences, Inc. (NASDAQ:APDN) a polymerase chai...

Via Benzinga

Applied DNA Sciences To Raise $4.2M Via Registered Direct Offering ↗

February 22, 2022

Applied DNA Sciences, Inc. (NASDAQ:APDN), a polymera...

Via Benzinga

Why Is Applied DNA (APDN) Stock Up 212% Today? ↗

August 02, 2022

Applied DNA (APDN) stock is rocketing higher on Tuesday after the company revealed its starting analytical validation of a monkeypox test.

Via InvestorPlace

Nasdaq Turns Positive; Crude Oil Moves Higher ↗

August 02, 2022

U.S. stocks pared losses midway through trading, with the S&P 500 and Nasdaq Composite turning higher on Tuesday.

Via Benzinga

Why Applied DNA Sciences Stock Is Soaring ↗

August 02, 2022

Applied DNA Sciences Inc (NASDAQ: APDN) shares are soaring Tuesday after the company initiated validation of its PCR-based monkeypox virus test.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 22, 2022

During Friday's session, 61 companies made new 52-week lows.

Via Benzinga

Earnings Scheduled For February 10, 2022 ↗

February 10, 2022

Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

June 28, 2022

On Tuesday, 87 companies hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 31, 2022

Gainers

Via Benzinga

Recap: Applied DNA Sciences Q2 Earnings ↗

May 12, 2022

Applied DNA Sciences (NASDAQ:APDN) reported its Q2 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Outlook For Applied DNA Sciences ↗

May 11, 2022

Applied DNA Sciences (NASDAQ:APDN) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 22, 2022

Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million....

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 17, 2022

Gainers Creative Medical Tech (NASDAQ:CELZ

Via Benzinga

Looking Into Applied DNA Sciences's Return On Capital Employed ↗

February 14, 2022

Applied DNA Sciences (NASDAQ:APDN) brought in sales totaling $4.17 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 4.73%, resulting in a loss of $4.72...

Via Benzinga

78 Biggest Movers From Friday ↗

February 14, 2022

Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 11, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI...

Via Benzinga

52 Weeks High And Low Article ↗

February 11, 2022

On Friday, 106 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Air Products & Chemicals (NYSE:APD) is the largest company...

Via Benzinga

41 Stocks Moving In Friday's Mid-Day Session ↗

February 11, 2022

Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations...

Via Benzinga

Recap: Applied DNA Sciences Q1 Earnings ↗

February 10, 2022

Applied DNA Sciences (NASDAQ:APDN) reported its Q1 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 15, 2021

Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 10, 2021

Gainers Quoin Pharmaceuticals (NASDAQ:

Via Benzinga

Applied DNA Sciences Earnings Perspective: Return On Capital Employed ↗

December 10, 2021

Benzinga Pro data, Applied DNA Sciences (NASDAQ:APDN) reported Q4 sales of $3.00 million. Earnings fell to a loss of $4.51 million, resulting in a 30.78% decrease from last...

Via Benzinga

18 Stocks Moving in Friday's Pre-Market Session ↗

December 10, 2021

Gainers Context Therapeutics Inc. (NASDAQ: CNTX) rose 48.6% to $9.30 in pre-market trading as the company announced data from ONA-XR in early breast cancer. The company said ONA-...

Via Benzinga

The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares ↗

December 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Angion Biomedica's ANG-3777 Does Not Meet Primary Endpoint In Mid-Stage...

Via Benzinga

Applied DNA Sciences' Q4 Revenues Skyrockets Buoyed By Momentum In COVID-19 Diagnostic Testing ↗

December 10, 2021

Applied DNA Sciences Inc (NASDAQ: APDN) reported a more than ninefold Y/Y increase in Q4 FY21 revenues, driven by the rise in clinical laboratory service revenues related to...

Via Benzinga

Applied DNA Sciences: Q4 Earnings Insights ↗

December 09, 2021

Applied DNA Sciences (NASDAQ:APDN) reported its Q4 earnings results on Thursday, December 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 09, 2021

Gainers Applied DNA Sciences (NASDAQ:APDN...

Via Benzinga

The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO ↗

December 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Applied DNA Sciences, Inc. - Common Stock (NQ:APDN)

Headline News about Applied DNA Sciences, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today